Trial intelligence / Profile preview

CASCADE: PDS0101 in People Living With HIV and HPV 16

NCT07090174Phase 2Withdrawn

Sponsor
University of California, San Diego
Start
Apr 2026
Primary completion
Dec 2026
Countries
2
01

Overview

A Phase 2 trial of PDS0101 in Human Papillomavirus Type 16 Infection, sponsored by University of California, San Diego. Planned start Apr 2026; status: withdrawn.

02

Drugs

PDS0101
03

Conditions

Human Papillomavirus Type 16 Infection

Beyond the preview

Go deeper on NCT07090174.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07090174.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call